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4ABSTRACT
Pajari A-M. Diet and colon protein kinase C: relation to intestinal tumour development in
experimental animals [dissertation]. Helsinki, University of Helsinki. 2000.
Colorectal cancer is one of the leading causes of cancer deaths in the Western countries and its
incidence rates are currently increasing in all industrialised societies. Environmental factors
including diet are considered to play a major role in colon tumourigenesis. A number of
epidemiological studies suggest that diets high in fat and red meat and low in fibre rich foods,
such as vegetables, fruits and cereals, are associated with an increased risk of colon cancer.
The aim of the present study was to elucide the mechanisms whereby diet may either prevent or
promote colon tumour development. Specifically, it was examined whether fat, red meat, and
different fibre sources are able to modify colonic PKC activity and isozyme expression in rat
colonic mucosa. Furthermore, levels of PKC activators, such as fatty acids in mucosal
phospholipids and diacylglycerol in colonic contents, were determined. The effects of fat, red
meat, and fibre sources on intestinal tumour development were studied in APCMin mice.
The results suggest that fats have no major effect on PKC activation or tumour development in
the intestinal mucosa of rats and Min mice. However, feeding of a high-beef diet resulted in
elevation of steady-state PKC activity in the colonic mucosa of rats as well as enhanced intestinal
tumour development in Min mice. The effects of different fibre sources on PKC and tumour
formation differed depending on the fibre type in question. The readily fermentable fibre sources
inulin and oat bran resulted in an increase in PKC activity and PKC β2 expression in rat colon
and enhanced tumour development in the intestine of Min mice, whereas wheat and rye brans
resulted in low PKC activity and PKC β2 expression together with suppressed tumour
development in Min mice.
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81. INTRODUCTION
Colorectal cancer is the fourth most common cancer in the world today (WHO 1997). Its
incidence rates vary approximately 20-fold around the world so that the high-risk areas include
North America, Europe, and Australia, whereas Central and South America, Asia, and Africa are
areas of low risk. In Finland, cancer of the colon and the rectum are the second and third most
common cancers in women and men respectively (Finnish Cancer Registry 2000). The number of
new cases per year has steadily increased since 1965, being now three times higher than in the
mid 1960s. The incidence rates of colon cancer are currently increasing in all industrialised
countries as well as in the urban areas of developing countries (WHO 1997).
The 20-fold international difference in colon cancer rates is generally explained by differences in
dietary habits and other environmental factors. In their much referred report, Doll and Peto
(1981) estimated that dietary factors may account for approximately 35% of cancer deaths,
although the range of their estimate was wide from as low as 10% to as high as 70%. Since the
early 1980s, a large body of evidence has emerged from epidemiological studies concerning the
relationship between diet and colon cancer, which was recently reviewed by the expert panel of
the World Cancer Research Fund (1997). The expert panel concluded that the most effective way
of preventing colorectal cancer is consumption of diets high in vegetables and low in red and
processed meat. Furthermore, consumption of diets high in non-starch polysaccharides (fibre),
starch and carotenoids and low in fat, sugar, and eggs possibly decreases the risk of colon cancer
(World Cancer Research Fund  1997).
Colon tumourigenesis is a multistep process affected by both environmental and genetic factors.
Over the past two decades, the genetic events involved in the initiation and progression of colon
cancer have been identified and a molecular model for colon tumourigenesis has been proposed
(Fearon and Vogelstein 1990, Kinzler and Vogelstein 1996). This model is currently widely
accepted to explain the development of the majority of colon tumours. According to this model,
normal epithelium progress to hyperplasia, early to intermediate to late adenoma, carcinoma, and
finally metastasis (Figure 1). The driving force in the tumourigenic process is accumulation of
mutations in key genes regulating cell growth, differentiation, and apoptosis, i.e. programmed
9cell death. These key genes can be classified into two major classes: the proto-oncogenes and the
tumour-suppressor genes. Activating mutations in proto-oncogenes generate oncogenes that
typically induce cell proliferation and thus abnormal growth. The most frequently mutated
oncogene in colon cancer is the RAS gene. Tumour-suppressor genes are needed for cell growth
arrest and apoptosis and therefore mutational inactivation of these genes leads to loss of negative
growth control. Among the tumour-suppressor genes important in colon cancer are the
adenomatous polyposis coli gene (APC), the deleted in colorectal carcinomas gene (DCC), and
the p53 gene.
One of the major issues of current research is to understand how dietary factors interact with the
genetic events to either enhance or suppress the tumourigenic process in the colon. Apart from
carcinogens derived from environmental or cooking processes, diet as such is not likely to cause
mutations in the key genes initiating colon carcinogenesis. However, the growth of both mutated
and normal cells is regulated by different cell signalling pathways which may be either activated
or suppressed by dietary constituents (Figure 1). One of these pathways consists of protein kinase
C (PKC) isozymes which have been shown to be involved in colonic cell growth and
differentiation as well as malignant transformation (Brasitus and Bissonnette 1998). Changes in
     
Normal Mucosa          Carcinoma
     Hyperplasia    Early Adenoma          Late Adenoma
                    
       APC                                 RAS                               p53
                        mutation                          mutation                          mutation
Figure 1. The adenoma-carcinoma sequence leading to colon cancer (modified from Fearon and
Vogelstein 1990 and Williams et al. 1997).
Diet and other environmental factors
Changes in expression and activity of signal transduction molecules,
e.g. PKC and COX-2
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PKC activity and isozyme expression are considered to occur at an early phase of colon
carcinogenesis and therefore the dietary effects on PKC may be of importance. Cyclooxygenase-
2 (COX-2) is generally recognised as perhaps even a more important contributor to colon
carcinogenesis than PKC isozymes (Williams et al. 1997). However, changes in COX-2
expression and activity take place presumably somewhat later during the carcinogenic process
when the possibilities of diet to modulate tumourigenesis are less promising. A number of other
signal transduction pathways are likely to be involved in colon carcinogenesis. The
sphingomyelin pathway is particularly interesting since it is capable of inducing apoptosis and
dietary sphingomyelin may have a specific role in regulation of this pathway in the colon (Duan
1998). Furthermore, the APC/β-catenin pathway is of major importance because mutations in the
APC gene are the initiating events for a vast majority of both inherited and sporadic colon cancer
cases (Kinzler and Vogelstein 1996). Mutations in the APC gene lead to epigenetic changes in
other members of the pathway, β-catenin in particular, and thus in proliferation, adhesion, and
migration of intestinal epithelial cells (Pennisi 1998). There is also evidence that the APC/β-
catenin pathway interacts with other cell signal pathways, for example with PKC isozymes
(Murray et al. 1999).
This dissertation focuses on the mechanisms whereby diet may either promote or prevent colonic
tumour formation. Special emphasis is laid on the dietary effects on the cell signal transduction
pathways of PKC isozymes, sphingomyelinases, and APC-β-catenin.
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2. CELL SIGNAL TRANSDUCTION PATHWAYS RELATED TO COLON CANCER
This section introduces those colonic signal transduction pathways that are within the scope of
this dissertation. These pathways include the PKC, APC/β-catenin, sphingomyelin, and
cyclooxygenase pathways. The PKC and APC/β-catenin pathways are described in detail because
the major part of the experimental work in this dissertation concentrates on these two pathways.
The sphingomyelin and especially cyclooxygenase pathways are introduced only briefly. The role
of each pathway in controlling cell fate in the intestinal epithelium as well as their involvement in
colon carcinogenesis is described. Figure 2 is an overview of these pathways and their possible
interactions in colonic cells.
2.1 Protein kinase C
Description of the pathway
PKC comprises a large family of serine and threonine-specific kinases. At least 11 different PKC
isozymes have been identified, of which colonic epithelial cells express α, β/β2, δ, ε,=ζ, and ι/λ
(Davidson et al. 1994, Kahl-Reiner et al. 1994, Wali et al. 1995). These PKC isozymes differ in
their activator requirements so that PKC α and β/β2 are so called conventional isoforms activated
by Ca2+, diacylglycerol (DAG), and phosphatidylserine (PS). PKC δ and ε are novel isoforms
activated by DAG and PS, whereas PKC ζ, and ι/λ are atypical isoforms stimulated by PS but not
by Ca2+ or DAG. In a classical model for PKC activation, interaction of an extracellular signal
with a receptor leads to formation of DAG and inositol triphosphate from cell membrane
phosphatidylinositol. This, with a concomitant increase in intracellular Ca2+, results in
translocation of PKC from the cytosol to the membrane and subsequent activation of the enzyme
(Nishizuka 1984). The events in the signal transduction proceed very rapidly and induce PKC
activity only temporarily. Long-term modulation of PKC activity requires sustained production of
PKC activators in cells, such as DAG via phospholipase D mediated breakdown of
phosphatidylcholine (PC) and phosphatidylethanolamine (PE) or free fatty acid and lyso-PC via
phospholipase A mediated breakdown of PC (Nishizuka 1995). More recent studies have
revealed that arachidonic acid (AA) and other cis-unsaturated fatty acids are also able to activate
12
Figure 2. Cell signal transduction pathways related to colon carcinogenesis. The molecules
analysed in the present study are indicated with bolding. AA, arachidonic acid; APC,
adenomatous polyposis coli protein; aPKC, atypical protein kinase C; COX-2, cyclooxygenase-
2; EGF, epidermal growth factor; GSK3β, glycogen synthase kinase 3β; MAPKs, mitogen-
activated kinases; NF-κB, nuclear factor κ-B; PGs, prostaglandins; PI3K, phosphoinositide 3-
kinase; c/nPKC, conventional/novel protein kinase C; sPLA2,, secreted phospholipase A2; PLC,
phospholipase C; PLD, phospholipase D; PPARs, peroxisome proliferator-activated receptors;
RTK, receptor-tyrosine kinase, TNFα, tumour necrosis factor α.   
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PKC (McPhail et al. 1984, Murakami et al. 1986, Khan et al. 1991). Fatty acids preferentially
activate soluble, cytosolic PKC and this activation is independent of or synergistic with the
phospholipids and Ca2+.
Variation in activator requirements, subcellular localisation, as well as tissue distribution enable
PKC isozymes to regulate a wide range of cellular functions, such as cell proliferation and
differentiation (Nishizuka 1995), cell cycle control (Thompson and Fields 1996, Livneh and
Fishman 1997), intracellular trafficking (Sanchez et al. 1998) or even apoptosis (Emoto et al.
1996). The specific functions of PKC isozymes in colon epithelial cells are not yet fully
understood. The evidence is most convincing in respect to PKC β2 and it suggests that PKC β2
mediates colonic cell proliferation. In colon carcinoma cells, overexpression of PKC β2 leads to
blocked differentiation, restoration of the response for the basic fibroblast growth factor, and
increased growth rate in athymic mice (Sauma et al. 1996, Sauma and Friedman 1996). These
effects were accompanied by the constitutive activation of mitogen-activated kinases (MAPK).
PKC α appears to be involved in colonic differentiation and growth arrest (Frey et al. 1997,
Abraham et al. 1998, Scaglione-Sewell et al. 1998). In human colon carcinoma CaCO-2 cells
transfected with antisense PKC α, decreased PKC α expression was associated with increased
proliferation, decreased differentiation, and a more transformed phenotype (Scaglione-Sewell et
al. 1998). The possible mechanism whereby PKC α mediates its antiproliferative effect may
involve induction of expression of p21waf1, a cell cycle regulatory protein (Frey et al. 1997,
Abraham et al. 1998). PKC α was shown to control the expression of adhesion molecules in
human colon carcinoma cells, thereby supporting the role of PKC α in differentiation.
(Chakrabarty et al. 1998). However, the study of Hochegger and co-workers (1999) argues
against the growth inhibitory role of PKC α in the colon. Instead, oligonucleotides directed
against PKC α and β resulted in inhibition of DNA synthesis, indicating that both isozymes
induce proliferation.
The two novel isoforms PKC δ and ε seem to have opposite functions in colonocytes. A recent
study with colon cancer cell lines demonstrated that activation of PKC ε triggers proliferative
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signals, whereas activation of PKC δ leads to apoptotic signals (Weller et al. 1999).
Immunohistochemical studies on PKC isozyme distribution along the colonic crypt axis also
support the role of PKC δ in mediating postmitotic events in colonocytes in situ (Kahl-Rainer et
al. 1996, Verstovsek et al. 1998).
Atypical PKCs ζ and λ can be activated by different growth factors (Akimoto et al. 1996, Liu et
al. 1998) and cytokines (Müller et al. 1995, Limatola et al. 1997) and they have been involved in
mediating growth, differentiation, and maturation in several cell types (Dominguez et al. 1992,
Berra et al. 1993, Liu et al. 1998). Suggested downstream targets of PKC ζ include at least the
κB nuclear factor (NF-κB; Lozano et al. 1994, Müller et al. 1995), the AP-1 transcription factor
(Ways et al. 1994), and MAPKs (Berra et al. 1995). PKC  ζ= has also been shown to interact with
the Ras protein in fibroblasts (Diaz-Meco et al. 1994) and to be involved in regulating the
endocytic membrane transport of the epidermal growth factor receptor in HeLa cells (Sanchez et
al. 1998). In normal rat colonic epithelium, PKC ζ has been found to be expressed predominantly
in the postmitotic cells of the upper crypt and surface mucosa, supporting a role for PKC ζ in
mediating maturation of colonocytes (Kahl-Rainer et al. 1996, Verstovek et al. 1998).
Role in colon cancer
A number of studies have shown that PKC activity and isozyme expression are changed during
colon carcinogenesis. PKC activity in colon tumours of both human (Guillem et al. 1987, Kopp
et al. 1991, Kusunoki et al. 1992, Levy et al. 1993) and animal origin (Baum et al. 1990, Wali et
al. 1991, Craven and DeRubertis 1992) is reduced when compared with the surrounding
uninvolved mucosa. In experimental animals, the levels of PKCs α, δ, and ζ have been down-
regulated and the levels of =β/β2 have been up-regulated in carcinogen-induced colon tumours
(Craven and DeRubertis 1992, Roy et al. 1995, Wali et al. 1995, Jiang et al. 1997a). However,
there are some inconsistencies in the human observations. Kahl-Rainer and co-workers (1994)
reported reduced protein expression of all PKCs except β that was neither decreased nor
increased. In contrast, the study by Davidson and co-workers (1994) showed increased levels of
all the PKC isozymes in adenocarcinomas when compared with the normal mucosa. The increase
was most pronounced in PKC β levels. One study demonstrated down-regulation of PKC β and ε
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and up-regulation of PKC δ, while no change occurred in the levels of PKC α and ζ (Pongracz et
al. 1995). This discrepancy in results between different studies is probably due to differences in
sample taking as well as in experimental procedures to analyse PKC activity and expression.
Several studies indicate involvement of PKC β2 in malignant transformation of colonocytes. In
carcinogen injected animals, both PKC β2 expression and membrane/particulate association were
increased in tumours relative to the uninvolved surrounding mucosa (Wali et al. 1995),
suggesting that membrane association of PKC β2 may be related to the growth advantage of
tumour cells. This is supported by a recent in vivo study showing that transgenic mice
overexpressing PKC β2 exhibit hyperproliferation in their colonic epithelium and have an
increased susceptibility to azoxymethane(AOM)-induced aberrant crypt foci (ACF),
preneoplastic lesions in the colon (Murray et al. 1999). PKC ε=has also been implicated in the
promotion of colon cancer. Perletti and co-workers (1996) showed that PKC ε=could act as an
oncoprotein when modestly overexpressed in nontumourigenic rat colonic epithelial cells. The
same group also demonstrated with an in vitro model of colon carcinogenesis that PKC δ
suppresses growth and reverses the transformed phenotype of the epithelial cells (Perletti et al.
1999). This result emphasises the potency of PKC δ in inhibiting the carcinogenic process. The
exact role of atypical PKC ζ and λ in colonic tumourigenesis is less well known. However, the
anti-inflammatory drug piroxicam was able to prevent the carcinogen-induced down-regulation
of PKC ζ in rat colon, which was associated with reduction in tumour incidence (Roy et al.
1995).
In summary, there are abundant data to show the central role of PKC isozymes in the normal
regulation of colonic proliferation and differentation as well as in malignant transformation.
However, the specific cellular functions of all the isozymes in the colon are not yet fully
understood, which makes the relation between PKC and colon carcinogenesis complex, though
not less important.
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2.2 Adenomatous polyposis coli/β-catenin
Description of the pathway
The following presentation of the APC/β-catenin pathway is mainly based on the reviews of
Barth et al. (1997), Ilyas and Tomlinson (1997), Ben Ze`ev and Geiger (1998), Eastman and
Grosschedl (1999), and Pennisi (1999). APC is a huge cytoplasmic protein that regulates cellular
β-catenin levels. In the cytoplasm APC forms a multiprotein complex with two other proteins,
glycogen synthase kinase 3β=(GSK3β) and axin. In this complex, APC binds β-catenin, GSK3β
phosphorylates both APC and β-catenin thereby strengthening their interaction as well as
marking β-catenin for degradation. Axin binds simultaneously and directly with β-catenin, APC,
and GSK3β, thus stimulating GSK3β-dependent phosphorylation and β-catenin degradation.
Wnt glycoproteins convey signals of growth and development between cells. The Wnt signalling
antagonises the activity of the APC-GSK3β-axin complex, resulting in an increase in free
cytoplasmic β-catenin. This signalling cascade is initiated by the binding of the secreted Wnt to
the Frizzeled family of transmembrane receptors. These receptors activate the cytoplasmic
phosphoprotein Dishevelled, which inhibits GSK3β activity, either directly or possibly through
PKC β2 (Cook et al. 1996, Murray et al. 1999). Inhibition of GSK3β=leads to accumulation of
hypophosphorylated and thus stabilised β-catenin in the cytoplasm. Stabilised β-catenin
relocalizes to the nucleus, where it binds to the transcription factor T cell factor-4 (Tcf-4),
thereby enhancing expression of several genes involved in cell growth. The putative target genes
of the β-catenin/Tcf-4 complex include the c-MYC oncogene (He et al. 1998), peroxisome
proliferator-activated receptor δ (PPARδ) gene (He et al. 1999), the cyclin D1 gene (Tetsu and
McCormick 1999), and others such as the connective tissue growth factor WISP genes (Pennica
et al. 1998), the transcription factor c-JUN and FRA-1 genes (Mann et al. 1999), and possibly the
cell surface glycoprotein CD44 gene (Wielenga et al. 1999).
In addition to the Wnt signalling, β-catenin also takes part in regulation of cell adhesion and
motility. The cellular β-catenin pool mediating adhesion is located in adherens junctions at the
plasma membrane. Adherens junctions are multiprotein complexes involved in cell-to-cell
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contacts. The heart of this complex are transmembrane E-cadherin proteins. The cytoplasmic tail
of E-cadherin binds β-catenin, which in turn complexes with α-catenin. α-catenin connects the E-
cadherin-β-catenin complex to the actin cytoskeleton through vinculin. This linkage to the actin
cytoskeleton is essential for the adhesion function of cadherins. Tyrosine phosphorylation of β-
catenin has been implicated in the negative regulation of cell adhesion (Barth et al. 1997,
Eastman and Grosschedl 1999). β-catenin can be tyrosine phosphorylated by the epidermal
growth factor receptor and non-receptor tyrosine kinases, which may lead to disruption of
interactions between=β-catenin and cadherin or cadherin-catenin complex and the cytoskeleton
(Hazan and Norton 1998, Rosato et al. 1998), and thus to decreased adhesion.
Role in colon cancer
The APC tumour suppressor gene is inactivated by somatic mutation in the majority of sporadic
colorectal tumours (Kinzler and Vogelstein 1996). Germline mutations in the APC gene cause
familial adenomatous polyposis (FAP), an autosomal dominantly inherited disease in humans that
predisposes to colorectal cancer. FAP patients develop hundreds to thousands of adenomas
predominantly in the lower gastrointestinal tract. If not removed, some of these tumours will
progress to cancer. Based on these observations, APC is considered as the gatekeeper for colonic
tumourigenesis. Altogether five murine models of human FAP have been created during the last
ten years (Alexander 2000, Sasai et al. 2000). These mouse strains possess an induced germline
mutation in the Apc gene which is a murine homologue of the human APC gene. Of these mouse
models, the Min mouse (Min, multiple intestinal neoplasia) has been used most frequently to
study the role of the Wnt/APC/β-catenin pathway in intestinal tumour development.
Inactivating mutation of the APC gene is an early, initiating event in colon carcinogenesis,
resulting in expression of truncated APC protein. Mutant APC protein is unable to down-regulate
β-catenin  (Morin et al. 1997), which is critical for APC’s tumour suppressor function. It is
considered that elevation of cytosolic free β-catenin leads to enhanced translocation of β-catenin
to the nucleus, its association with the Tcf-4 transcription factor, and thus abnormal
transcriptional activity of the genes promoting cell proliferation. Indeed, colon carcinoma cells
mutant for APC contain a stable β-catenin/Tcf-4 complex in the nuclei that is constitutively
active (Korinek et al. 1997). Reintroduction of wild-type APC removed β-catenin from Tcf-4 and
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inhibited transcriptional activation in these cells. In addition to APC mutations, activating
mutations in the β-catenin gene can also result in elevated β-catenin/Tcf-4 mediated
transcriptional activation (Morin et al. 1997). The role of β-catenin in colon tumourigenesis is
further supported by studies showing that tumour cells from colorectal cancer patients exhibit
reduced β-catenin in the cytoskeletal fraction and increased β-catenin in the cytosolic and nuclear
fractions (Herter et al. 1999, Hugh et al. 1999).
APC and β-catenin may affect colonic tumourigenesis partly through their effects on cell
adhesion and thus on cell-to-cell interactions, which is independent of the Wnt pathway
regulating cell proliferation. In Min mice, the histologically normal intestinal epithelium revealed
elevated β-catenin levels and changes in proliferation and apoptosis, which were associated with
decreased rate of crypt-villus migration (Mahmoud et al. 1997). This abnormal migration could
be due to disturbances in function of β-catenin/E-cadherin complexes in the adherens junctions.
E-cadherin has been suggested to act as a tumour suppressor gene (Christofori and Semb 1999)
and the loss of E-cadherin mediated cell adhesion has been demonstrated to be causally involved
in the progression from adenoma to carcinoma in vivo (Perl et al. 1998). Because β-catenin is
essential for the adhesion function of cadherins, changes in intracellular β-catenin distribution are
likely to affect cell adhesion. The role of APC protein in adhesion is less clear though it is known
that wild-type APC associates with the cytoskeleton by binding microtubules, while the mutated
APC does not (Munemitsu et al. 1994). This suggests that APC may also be involved in β-
catenin mediated cell-to-cell signalling.
2.3 Sphingomyelinase
Description of the pathway
Sphingolipids are located in cellular membranes and are important for the maintenance of
membrane structure. Recent studies have revealed that sphingolipids, sphingomyelin in
particular, may also serve as substrates for a cell signal transduction pathway related to cell
growth suppression (reviewed by Duan 1998). Activation of sphingomyelinases results in
hydrolysis of sphingomyelin and formation of ceramide, a putative lipid second messenger.
Ceramide has been shown to induce apoptosis and cell cycle arrest (Obeid et al. 1993, Jayadev et
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al. 1995) as well as inhibit cell proliferation and stimulate cell differentiation (Okazi et al. 1990,
Hannun 1994). Ceramide may be further metabolised to sphingosine which can either be re-
acylated back to ceramide or be phosphorylated to sphingosine-1-phosphate (Shimojo and
Schroepfer 1976, Hassler and Bell 1993). Sphingosine inhibits growth and induces apoptosis
(Hannun 1994, Jayadev et al. 1995), whereas sphingosine-1-phosphate promotes proliferation
and inhibits apoptosis (Olivera and Spiegel 1993, Cuvillier et al. 1998).
Three types of sphingomyelinases differing in their pH optimum and cellular localisation have
been identified. Acid sphingomyelinase is a lysosomal enzyme with an optimal activity at pH 5.0
(Spence 1993). Neutral sphingomyelinase presumably exists in two different forms. The classical
form is a plasma membrane associated enzyme with a requirement for Mg2+ ions and a pH
optimum at 7.4 (Chatterjee 1993). A soluble Mg2+ -independent neutral sphingomyelinase has
been reported to be present in the cytosol (Okazi et al. 1994). Acid and neutral
sphingomyelinases are expressed ubiquitously in mammalian tissues. Alkaline sphingomyelinase
with a pH optimum of 9.0 is specific to the intestinal tract (Nilson 1969). Its activity is high in the
small intestine and still considerable in the colon, with a decreasing gradient towards the rectum
(Duan et al. 1996). Sphingomyelinases can be activated by a variety of extracellular agonists,
such as tumour necrosis factor α, interferon-γ, interleukin-1β, and 1,25-dihydroxy vitamin D3.
Environmental stress factors including heat shock and ionising and ultraviolet radiation are also
known inducers of sphingomyelin hydrolysis (for a review see Kolesnick and Krönke 1998).
Ceramide produced by sphingomyelinases is thought to mediate its effects on cell functions
through altering the phosphorylation status of proteins and thus the activity of transcriptional
factors, for example inducing c-MYC down-regulation (Duan 1998). Ceramide produced by acid
sphingomyelinase may have a specific role in activating atypical PKC ζ=, which in turn leads to
activation of the transcriptional factor NF-κB (Lozano et al. 1994, Müller et al. 1995). Ceramide
might also inactivate PKC α by causing dephosphorylation of the enzyme (Jones and Murray
1995). Another member of the sphingomyelin pathway, sphingosine, is known to interact with
PKC since an early study showed that sphingosine is an inhibitor of PKC activity (Hannun et al.
1986).
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Role in colon cancer
Several types of findings indicate that sphingomyelinases may play an active role in colonic
malignant transformation. Sphingomyelin levels are increased in human colon carcinomas as well
as in the colonic mucosa of carcinogen-treated rats (Dudeja et al. 1986, Merchant et al. 1995). In
FAP patients, the activities of all the three types of sphingomyelinases are reduced in colorectal
carcinomas compared with the surrounding tissue (Hertervig et al. 1997). In mice treated with
dimethylhydrazine, supplementation of the diet with sphingomyelin reduces the number of ACF
and the appearance of adenocarcinoma in the colon (Dillehay et al. 1994, Schmeltz et al. 1997).
Certain dietary constituents, such as dairy products and meat, contain sphingomyelin as well as
other cell membrane phospholipids (Blank et al. 1992), which might affect colonic sphingolipid
signalling and thus colon tumourigenesis. Although promising, the evidence regarding the role of
sphingolipids in colon carcinogenesis is based on relatively few studies and therefore
comprehensive conclusions are not yet possible.
2.4. Cyclooxygenase
Cyclooxygenase (COX) catalyses the conversion of arachidonic acid (AA) to prostaglandin
endoperoxide H2, which is the direct precursor of various prostaglandins,
hydroxyeicosatetraenoic acids, and other eicosanoids. Two isoforms of COX exist: COX-1 is
constitutively expressed in many tissues and cell types, whereas COX-2 is an inducible form
frequently up regulated by mitogens, cytokines, and tumour promoters (Williams et al. 1997).
The two isoforms have both overlapping as well as distinct physiological and pathological
functions.
Role in colon cancer
Elevated COX-2 expression is currently presumed to play an important role in colon
tumourigenesis. Human colon adenocarcinomas have been demonstrated to have increased COX-
2 expression when compared to normal adjacent mucosa (Eberhart et al. 1994). These findings
are supported by animal studies that have shown elevated levels of COX-2 in colon tumours of
carcinogen-treated rats (DuBois et al. 1996) and intestinal adenomas of Min mice (Williams et al.
1996). Furthermore, treatment with sulindac, a non-steroidal anti-inflammatory drug (NSAID)
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inhibiting both COX-1 and COX-2, markedly reduced tumour formation as well as decreased
COX-2 expression and prostaglandin E2 (PGE2) levels in the intestine of Min mice (Boolbol et al.
1996). Celecoxib, a specific COX-2 inhibitor, suppressed AOM-induced tumour number and
incidence in rats by more than 90% (Kawamori et al. 1998). These results suggest a causative
role for COX-2 in colonic tumour promotion, which is probably mediated by enhanced
production of PGE2. The mechanisms of the tumour promotive action of PGE2 may involve
inhibition of apoptosis due to increased Bcl-2 protein levels (Sheng et al. 1998) and induction of
angiogenesis (Tsujii et al. 1998). However, it is noteworthy that the tumour suppressive effect of
NSAIDs may not be entirely mediated through COX inhibition because NSAIDs induced
apoptosis in colon cancer cell line has been shown to be independent of PGE2 (Earnest et al.
1997).
A number of studies have also suggested a close interaction between COX-2 and the APC-β-
catenin pathway (reviewed in Prescott and White 1996). The most convincing evidence for this
interaction comes from a study by Oshima and co-workers (1996). They introduced a knockout
mutation of the COX-2 gene to the Apc∆716 mice and found that the number and size of intestinal
polyps in the mice with a disrupted COX-2 gene were dramatically reduced when compared to
mice with a fully functioning COX-2 gene. It has been hypothesised that loss of both APC alleles
at the early stage of the cancer process will induce COX-2 expression, leading to self-promotion
of tumourigenesis (Prescott and White 1996).
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3. EPIDEMIOLOGICAL AND EXPERIMENTAL EVIDENCE ON DIET AND COLON
CANCER
This section gives a brief overview of the epidemiological and experimental evidence concerning
the role of fat, red meat, and fibre rich foods in colon cancer. Because of the large body of
evidence, only the studies considered to be most significant are referred here. The other dietary
factors possibly associated with colon cancer are calcium, folates, vitamin D, vitamin E,
carotenoids, and selenium. They are not within the scope of this work and are not reviewed here.
Interested readers are referred to the World Cancer Research Fund report (1997). The purpose of
this section is to offer a background to help the reader understand the mechanistic approach used
in Studies I - VI of this dissertation.
3.1 Fat
Ecological studies, most of which were carried out in the 1970s, have reported a strong
correlation between national per capita consumption of fat and mortality or incidence of
colorectal cancer (see Potter et al. 1993). Based on these studies, the leading hypothesis until the
beginning of the 1990s has been that dietary fat is the most important dietary risk factor for colon
cancer. Most of the results from the earlier case-control studies have supported this hypothesis
(Potter et al. 1993). However, a number of these studies did not distinguish fat intake from total
energy intake. Fat and energy intakes are highly correlated with each other, and animal studies
have shown that energy intake is a strong determinant of tumour growth in chemically induced
colon carcinogenesis (Klurfeld et al. 1987). Therefore, the results of the earlier case-control
studies may have been misinterpreted. A recent combined analysis of 13 case-control studies
found no independent effect of fat on colon cancer risk after adjustment for total energy intake
(Howe et al. 1997). Moreover, of the four prospective cohort studies that controlled for the total
energy intake (Willet et al. 1990, Bostick et al. 1994, Giovannucci et al. 1994, Goldbohm et al.
1994), none found a significant positive association between total fat and the risk of colon cancer.
In respect of the subgroups of fat, the Nurses’ Health Study (Willet et al. 1990) reported a
twofold higher risk of colon cancer in women in the highest quintile compared with those in the
lowest quintile of animal fat intake. The other three studies did not find any association between
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animal, vegetable, or polyunsaturated fat and the risk of colon cancer (Bostick et al. 1994,
Giovannucci et al. 1994, Goldbohm et al. 1994).
A considerable number of experimental studies with rodent colon carcinogenesis model have
been conducted to elucidate the effects of fat quantity and type on colonic tumour development.
In some studies, diets high (20% by weight) in corn oil, safflower oil, beef tallow or lard have
increased the incidence of colon cancer in carcinogen-treated rats compared with low fat diets
(5% by weight) (Reddy 1992). No promoting effect on colonic tumourigenesis could be seen
when rats were fed large amounts of olive oil, coconut oil, fish oil or hydrogenated fat high in
trans fatty acids (Reddy 1992). For corn oil and beef tallow, there are experiments that have
shown no increase in tumour incidence even though the level of these fats in diets has been 24%
by weight (Nauss et al. 1983). The discrepancy in results between different studies is probably
due to differences in the experimental procedures, including the species, strain, and sex of
animals used. The type of carcinogen and its administration way have also varied among the
studies. A quantitative analysis of 14 studies of rat colon carcinogenesis demonstrated a rather
strong positive relationship between total fat intake and tumour incidence in F344 rats but not in
Sprague-Dawley rats (Zhao et al. 1991). When the type of fat was taken into account, the results
for both strains suggested a negative relationship between tumour incidence and n-3 fatty acids.
A positive relationship between n-6 polyunsaturated fatty acids and tumour incidence was seen in
F344 rats only, while monounsaturated and saturated fats were not associated with
tumourigenesis (Zhao et al. 1991).
Dietary fats have also been studied in Apc mutated mice characterised by the development of
spontaneous intestinal tumours along the entire intestine. In Min mice, a diet high in corn oil
(15% by weight) and thus high in polyunsaturated n-6 fatty acids was found to increase adenoma
number in both the small and large intestine (Wasan et al. 1997), supporting the results of some
earlier rat studies. Two studies have examined the role of n-3 fish oil fatty acids in colon tumour
development. In the first study, supplementation of AIN76A diet with 3% of docosahexaenoic
acid (DHA) decreased tumour number in the intestine of Apc∆716 mice, though only in females
(Oshima et al. 1995). In the second study, Min mice were fed varying amounts of
eicosapentaenoic (EPA) and DHA enriched fish oil concentrate that was mixed with corn oil so
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that the total oil content in the AIN76A-based diets was 12% (Paulsen et al. 1997). The fish oil
concentrate reduced tumour number in both male and female mice when compared with the
control group which had 12% pure corn oil in the diet (Paulsen et al. 1997). Taken together,
recent epidemiological studies do not support a promotive effect of fat on colon cancer.
Experimental studies strongly suggest that fish oil rich in n-3 fatty acids protects against colon
cancer, whereas the role of saturated and n-6 fatty acids has been partly controversial.
3.2 Red meat
Although early ecological and case-control studies suggested that red meat consumption is
positively associated with colon cancer risk, the promotive effect of red meat on colon
carcinogenesis was mostly attributed to the fat content of meat. In the beginning of the 1990s,
two large cohort studies in the U.S. demonstrated that intake of red meat is a stronger risk factor
for colon cancer than total fat intake (Willett et al. 1990, Giovannucci et al. 1994). The Health
Professionals Follow-Up Study, in particular, found a direct association between red meat
consumption and colon cancer risk while no association was observed with total fat or animal fat
(Giovannucci et al. 1994). These results have only partly been supported by the other recent
cohort studies. In the cohort study from the Netherlands, consumption of processed meats but not
fresh meat was related to an elevated colon cancer risk (Goldbohm et al. 1994), whereas four
other cohorts showed no increase in risk with meat consumption (Thun et al. 1992, Bostic et al.
1994, Knekt et al. 1994b, Kato et al. 1997). The most recent cohort study reported an elevated
risk in Seventh-day Adventists in association with higher intakes of both red and white meat
(Singh and Fraser 1998).
So far seven studies have determined the effects of red meat on colon carcinogenesis in
experimental animals. The results have been mixed and extremely difficult to interpret because of
the differences in other components than the protein source of the experimental diets. An early
study demonstrated that beef and soybean proteins did not differ in their effects on colonic
tumour development. Feeding diets high in both beef or soybean resulted in an increased number
of total adenomas and adenocarcinomas in rat colon compared with feeding their low-protein
counterparts (Reddy et al. 1976). The studies by Nutter and co-workers (1983 and 1990)
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suggested that milk proteins might be more tumour promoting than beef, but the experimental
diets used in these studies differed in respect to type and amount of fat and therefore the
comparisons between beef and milk proteins may not be valid. Three studies have controlled for
the fat content of the diets. Of these studies, one examined the effects of red meat (kangaroo
skeletal muscle), soybean meal, casein, and whey concentrate on colonic tumour development in
rats and found that red meat- and soybean-fed animals had significantly higher number of
intestinal tumours than those fed dairy proteins (McIntosh et al. 1995). The other two studies
compared beef to casein, with results showing either no difference in tumour development
between beef- and casein-fed rats (Lai et al. 1997) or a slightly suppressive effect of beef in a
low-fat context (Pence et al. 1995a). A recent study by Parnaud and co-workers (1998) found no
difference in multiplicity of colonic ACF in carcinogen-treated rats fed diets high in beef,
chicken, or bacon. The limitation of this study is that though ACF are considered to be the
earliest precursors of colonic tumours, their multiplicity has not always correlated with adenoma
incidence (Hardman et al. 1991). Overall, the epidemiological findings are generally supportive
of the promotive effect of red meat on colon carcinogenesis but experimental evidence for this is
very inconsistent and limited.
3.3 Fibre rich foods
The hypothesis that high-fibre diets protect against colorectal cancer is several decades old and
has been the subject of numerous studies. Case-control studies have generally supported the
protective role of fibre in colon cancer. A combined analysis of 13 case-control studies
demonstrated a strong, linear reduction in colon cancer risk with increasing fibre intake (Howe et
al. 1992). Prospective studies have not confirmed the findings from case-control studies. Of four
prospective studies, two found no association (Willett et al. 1990, Giovannucci et al. 1994) and
two only a weak protective association (Heilbrun et al 1989, Steinmetz et al. 1994). Importantly,
a very recent study containing a large cohort of nurses found no significant protective effect
against colorectal cancer of total dietary fibre, or fibre from cereals, vegetables, or fruits (Fuchs
et al. 1999). In this population, fibre from vegetables contributed most and cereal fibre least to
the total fibre intake. One reason for the discrepancy between the case-control and prospective
studies may be differences in study populations; all the prospective studies have been done in the
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USA while populations in case-control studies have represented several nationalities with
differing dietary practices. The other reasons for inconsistent results most likely involve the
heterogeneous nature of fibre and fibre sources as well as differences in measuring fibre intake. It
is also possible that other substances associated with fibre-rich foods, such as vitamins, minerals,
phytate, and phytoestrogens, may account for the protective effect of fibre-rich foods. Whole-
grain products are a rich source of both the bioactive compounds and fibre, and whole-grain
intake has been associated with a reduced risk for colon cancer in two recent meta-analyses
(Jacobs et al. 1995 and 1998).
The effects of different fibre sources on experimental colonic tumour development have been
studied by using both carcinogen-treated rats and Apc mutated mice. The most studied fibre
sources include cereal brans, cellulose, and fibres extracted from various vegetables and fruits
such as carrots, sugar beets, and citrus fruits. Fruit and vegetable fibres are classified as soluble
fibres, based on their water solubility, and grain fibres as insoluble fibres. Oat fibre is an
exception since it contains considerable amounts of soluble fibre. The most consistent finding in
experimental colon cancer studies has been that wheat bran prevents tumour formation in the
colon of both rats (McIntry et al. 1993, Alabaster et al. 1995, Zoran et al. 1997) and Apc mutated
mice (Hioki et al. 1997). The results for other fibre types have been less consistent but in general
soluble fibres, such as oat bran, pectin, and guar gum, have increased rather than decreased the
number and incidence of colonic tumours in animal models (Jacobs and Lupton 1986, McIntry et
al. 1993, Zoran et al. 1997). Although whole grain rye products are consumed in large quantities
in Northern and Eastern Europe, only one study of the effects of rye bran on experimental colon
tumourigenesis has been published. In that study rye supplementation was shown to decrease
colonic tumour development in carcinogen-treated rats (Davies et al. 1999). This result is
expected since the composition of rye bran is close to that of wheat bran so that the two brans are
rich sources of both fibre and bioactive compounds, e.g. phytate and phytoestrogens (Mazur and
Adlercreuz 1998). Taken together, it seems that the protective effect of fibre is dependent on the
fibre type and that high-fibre foods contain other constituents that may independently or in
interaction with fibre contribute to colon cancer protection. This complex nature of the
relationship between fibre rich foods and colon carcinogenesis may also explain the inconsistent
results obtained in fibre studies.
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4. PROPOSED MECHANISMS OF FAT, RED MEAT, AND FIBRE RICH FOODS IN
COLON CARCINOGENESIS
4.1 Mechanisms related to fat  
Over the past decades, modulation of intestinal bile acid metabolism and prostaglandin
production have been the two leading hypotheses whereby dietary factors are thought to affect
colon carcinogenesis (Figure 3). Especially fat is considered to act through these mechanisms but
also the effects of red meat and fibre may be partly explained by bile acids and prostaglandins.
Therefore this chapter contains some discussion concerning red meat and fibre although the
major subject is fat.
4.1.1 Bile acids and protein kinase C
Bile acid metabolism
Over 95% of primary bile acids, cholic acid and chenodeoxycholic acid, are reabsorbed in the
terminal ileum and returned to the liver through the portal vein (Nagengast et al. 1995). The
remaining 2-5% continue into the colon where they are converted to secondary bile acids,
deoxycholic acid and lithocholic acid, by anaerobic bacteria. The bacterial enzyme thought to be
responsible for the conversion is 7α-dehydroxylase (Reddy et al. 1996). The secondary bile acids
are postulated to have detrimental effects on the colonic epithelium and thus promote colon
cancer. Animal studies have demonstrated that bile acids induce hyperproliferation of colonic
epithelial cells (Lapre’ and Van der Meer 1992) and promote colonic tumourigenesis (Reddy et
al. 1977, McSherry et al. 1989). Studies with cancer cell lines indicate that the proliferative and
thus the tumour promoting effect of bile acids is likely to be mediated by their ability to induce
the activity of the transcription factor AP-1 (Hirano et al. 1996, Matheson et al. 1996,
Glinghammar et al. 1999). An early human study by Reddy and Wynder (1973) also described a
positive association between the incidence of colon cancer and faecal bile acid excretion.
Dietary fat is thought to promote tumourigenesis by increasing bile acid excretion, and thereby
luminal concentrations of secondary bile acids in the colon (Figure 3, Potter 1993, Nagengast et
28
Dietary 
factors
           
         
Colonic  +
lumen       
                      
 
Colonic
mucosa
                                                            
                     
Figure 3. Possible mechanisms whereby dietary fat, meat, and fibre may affect colon tumour
development (modified from Reddy et al. 1996). AA, arachidonic acid; BA, bile acid; COX,
cyclooxygenase; DAG, diacylglycerol; EPA, eicosapentaenoic acid; PGs, prostaglandins; PLA2,
phopholipase A2; PLC, phospholipase C; PKC, protein kinase C; SCFA, short-chain fatty acid.
al. 1995). Because diets high in meat tend to be high in fat, the relationship between red meat
consumption and colon cancer has often been explained by the bile acid hypothesis. Dietary fibre
may prevent colon tumourigenesis by increasing stool bulk, which binds and dilutes bile acids,
and reduces transit time. This results in a shorter exposure of colonic epithelium to bile acids as
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well as to other potentially toxic compounds. Bacterial fermentation of fibre produces short-chain
fatty acids that decrease luminal pH and thereby inhibit the conversion of primary to secondary
bile acids  (Potter 1993). The experimental evidence concerning the bile acid hypothesis has not
been entirely supportive. Though diets high in corn oil have usually resulted in elevated levels of
secondary bile acids in faeces of experimental animals (Reddy et al. 1996), diets high in saturated
fats, such as butter and beef tallow, have not increased faecal bile acids (Chang et al. 1994,
Morotomi et al. 1997).
Bile acids and PKC
A more recent suggestion is that the interaction of fat, bile acids, and bacteria results in an
excessive production of luminal DAG, a physiological activator of PKC (Morotomi et al. 1990).
Indeed, it has been demonstrated that the colonic bacteria of human faecal specimens produce
DAG and this production is enhanced by the presence of bile acids, the secondary bile acid
deoxycholic acid being most potent in this respect (Morotomi et al. 1990). Luminal DAG was
also taken up by mucosal cells (Morotomi et al. 1991), indicating that luminal DAG would be
able to activate mucosal PKC pathway and thus stimulate cell proliferation.
Bile acids may also stimulate mucosal PKC activity directly. This is supported by the
observations that both primary and secondary bile acids are potent activators of PKC extracted
from human colon tissue samples (Pongracz et al. 1995) and that cholic acid feeding activates
mucosal PKC in rats (Pence et al. 1995b). Bile acids are also known to activate PKC in colon
cancer cell lines (Huang et al. 1992, Hirano et al. 1996). There is some evidence that bile acids
may be able to stimulate the activities of mucosal PLC (Nomoto et al. 1994) and PLA2
(DeRubertis et al. 1984) which in turn activate PKC by liberating DAG and AA from mucosal
phospholipids, respectively (Figure 3, Reddy et al. 1996). Colonic bacteria are known to exhibit
PLC activity (Reddy et al. 1996) and may therefore contribute to luminal DAG production. It has
also been suggested that specific fatty acids in red meat, such as palmitic acid (C16:0), may lead
to the formation of highly mitogenic DAG species (Friedman et al. 1989, Giovannucci and
Goldin 1997).
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It has been demonstrated that both dietary fat and fibre affect the composition and amount of
faecal DAG in rats (Pickering et al. 1995) and that fibre supplementation can reduce faecal DAG
concentration in humans (Reddy et al. 1994). Neither of these studies determined whether these
alterations in DAG were associated with mucosal PKC activity. In accordance with this
hypothesis, Reddy and co-workers (1996) found that carcinogen-treated rats fed a high corn oil
diet had higher levels of secondary bile acids and higher activities of bacterial 7α-dehydroxylase
and PLC as well as a lower mucosal activity of membrane PKC than rats fed a high fish oil diet
or a low fat control diet. In contrast, the study of Chapkin and co-workers (1993) showed an
increase in membrane PKC activity and membrane:cytosol ratio in rats fed fish oil compared to
corn oil-fed rats. The same study found no difference between the effects of pectin and cellulose
on PKC activity. Furthermore, feeding a diet containing 5% corn oil and 15% beef tallow
resulted in an increase in colon membrane PKC activity relative to a group fed a low corn oil diet
(Lafave et al. 1994). More recent studies have focused on the effects of corn oil and fish oil on
colonic PKC isozyme expression (Davidson et al. 1995, Jiang et al. 1997a). The results of these
studies suggest that the protective effect of fish oil against colon cancer may be partly mediated
through fish-oil induced changes in expression of specific PKC isozymes during the carcinogenic
process. Overall, relatively few studies have examined the effects of diet on colonic PKC activity
and isozyme expression, and because of the mixed results only limited conclusions can be made.
4.1.2 Prostaglandin production
An extensively studied mechanistic hypothesis has been that dietary fats affect colon
carcinogenesis through modulating the production of prostaglandins and other eicosanoids in the
colonic mucosa. This hypothesis is supported by a number of human and animal studies showing
that NSAIDs, inhibitors of COX enzymes, reduce both colonic prostaglandin biosynthesis and
tumourigenesis. Favourable dietary fat composition is thought to modulate phospholipid fatty
acid composition of mucosal cell membranes so that less AA would be available for
prostaglandin biosynthesis. This appears to be true for fish oil. For example, supplementation of
healthy volunteers with fish oil providing 4.4 g n-3 fatty acids per day for four weeks resulted in
decreased proliferation and PGE2 release from rectal biopsy specimens (Bartram et al. 1993). In
rats, feeding diet high in fish oil led to significantly lower AA content of mucosal phospholipids
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and lower PGE production when compared to feeding diets high in corn oil or beef tallow (Lee et
al. 1993). A recent study with carcinogen-treated rats demonstrated that rats fed fish oil had
decreased COX-2 expression as well as decreased tumour multiplicity and incidence when
compared with rats fed corn oil (Singh et al. 1997). Furthermore, supplementation with EPA
resulted in significant reductions in the AA content of phospholipids, PGE2 formation, and
tumour number in the intestine of Min mice (Hansen Petrik et al. 2000). These results confirm
that when dietary manipulation is able to suppress colonic prostaglandin production, it is also
likely to inhibit tumourigenesis. However, apart from large amounts of fish oil, there have been
no significant differences between the effects of saturated fats, mainly from animal origin, and
unsaturated fats, mainly vegetable oils with high linoleic acid content, on colonic AA levels and
prostaglandin production (Lee et al. 1993). Administration of pure AA at low to moderate
amounts has been shown to lead to its effective incorporation into tissue phospholipids and
enhanced prostaglandin production in experimental animals (Whelan et al. 1993). Therefore it is
possible that dietary AA, contributed by red meat intake, might be able to modulate eicosanoid
production to a significant extent.
4.2 Mechanisms related to red meat
Heterocyclic amines
A much-favoured hypothesis is that the promotive effect of red meat on colon cancer can be
explained by heterocyclic amines (HCA) that are formed during high-temperature cooking of
meat. HCAs are mutagenic (Wakabayashi et al. 1992) and PhIP (2-amino-1-methyl-6-
phenylimidatzo[4,5-b]-pyridine), the most abundant HCA in well-cooked meats, has been shown
to induce intestinal tumours in rats (Ito et al. 1991) and Min mice (Steffensen et al. 1997, Paulsen
et al. 1999). Furthermore, a recent study of Pence and co-workers (1998) demonstrated that the
feeding of a beef diet containing high levels of HCA enhanced colon tumour formation in
dimethylhydratzine-treated rats when compared with the corresponding diet low in HCAs,
although this was seen only in the low-fat context. A positive relation between cooking processes
and colon cancer risk has also been observed in some epidemiologic studies. A Swedish case-
control study found an elevated colon cancer risk among those meat eaters who frequently
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consumed brown gravy and preferred meat with a heavily browned surface (Gerhardsson de
Verdier et al. 1991).
The cancer risk related to HCAs may also depend on the extent to which HCAs are activated in
the body. Cytochrome P4501A2 and N-acetyltransferase-1 and -2 are responsible for the
metabolic activation of HCAs and all the three enzymes are known to be polymorphic in humans.
The N-acetyltransferase genotype, in particular, may be associated with colon cancer risk so that
red meat eaters may be at higher risk of colorectal cancer if they are rapid acetylators (Chen et al.
1998).
N-nitroso compounds
One possibility is that diets high in red meat lead to increased protein fermentation within the
colon, resulting in enhanced formation of endogenous carcinogens and tumour promoters. The
amount of protein in the diet is a primary determinant of the amount of nitrogen, mainly in the
form of protein, peptides, and amino acids, entering the colon (Silvester and Cummings 1995).
These nitrogen sources could be fermented by colonic bacteria to potentially harmful or toxic
substances, such as ammonia and N-nitroso compounds. High luminal ammonia concentrations
have been associated with increased cell proliferation (Lin and Visek 1991a and 1991b), and
ammonia has been shown to promote colon carcinogenesis in the rat (Clinton et al. 1988).
Luminal N-nitroso compounds may be an important source of DNA-damaging alkylating agents
which may produce base substitutions characteristic of those found commonly in colon tumours
(Saffhill et al. 1985, Jacoby et al. 1993). In human volunteers, high red meat consumption (600g
per day) led to increased plasma urea and faecal ammonia levels, and 3-fold increase in faecal N-
nitroso compounds, whereas consumption of 600 g white meat and fish had no such effect
(Bingham et al. 1996, Silvester et al. 1997). The authors concluded that the increase in faecal N-
nitroso compounds is brought about by a specific effect of red meat and may be partly due to
heme iron being a catalyst for N-nitroso compound formation.
Iron
The high iron content of red meat may also contribute to colon carcinogenesis. It has been
suggested that iron increases colon cancer risk either by elevating faecal iron (Babbs 1990) or by
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elevating tissue iron (Toyokuni 1996). High amounts of unabsorbed faecal iron may lead to
enhanced generation of free radicals at the mucosal surface of the colon and thus to increased
lipid peroxidation and DNA damage. In addition, iron may catalyse the formation of tumour
promoters or the conversion of pro-carcinogen to carcinogen within the lumen of the colon
(Babbs 1990). Excess plasma iron in the form of iron-transferrin may stimulate mucosal cell
proliferation by providing biologically available iron for cell growth. Alternatively, iron overload
could induce oxidative stress leading to tissue damage (Toyokuni 1996).
In line with these hypotheses, high dietary iron was shown to increase crypt cell proliferation and
tumour development in the colon of carcinogen-treated rats (Nelson et al. 1989). However,
dietary iron at a level more representative of human intake had no effect on cell proliferation,
lipid peroxidation, or ACF development in AOM-treated rats (Soyars and Fischer 1998). Studies
in humans have supported the positive association between body iron stores and colon cancer risk
(Knekt et al. 1994a, Wurzelman et al. 1996). Knekt and co-workers (1994a) found an elevated
risk of colon cancer in men and women with transferrin saturation over 60%. Another recent
study reported a positive relationship between colon cancer and serum iron in women
(Wurzelman et al. 1996).
4.3 Mechanisms related to fibre rich foods
Butyrate
In addition to the bulking effect and dilution capacity, dietary fibre may affect colon
carcinogenesis through its fermentation products, such as butyrate, propionate, and acetate. Of
these short-chain fatty acids, butyrate has been suggested to play an important role in colon
cancer prevention. Butyrate is the principal energy source of the epithelial cells (Roediger 1982)
and it also takes part in regulation of cell proliferation, differentiation, and apoptosis. The effects
of butyrate on these cellular processes have often been opposite in normal colonocytes relative to
neoplastic colonic cells. In normal colonocytes butyrate has been shown to increase cell
proliferation (Sakata 1987, Lupton and Kurtz 1993), whereas in colon cancer cell lines butyrate
has promoted expression of differentiation markers (Whitehead et al. 1986) and induced
apoptosis (Hague et al. 1995). The growth inhibitory effect of butyrate in colon cancer cells may
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be mediated by histone hyperacetylation and induction of p21waf1, a cell cycle regulatory protein
(Archer et al. 1998).
Experimental colon cancer studies partly support the protective effect of butyrate in vivo. McIntry
and co-workers (1991) demonstrated that rats fed wheat bran maintained relatively high butyrate
concentrations in the luminal contents along the entire length of their large intestine, particularly
in the distal colon. In a further study they showed that wheat bran reduced colonic tumour
development and that tumour mass was negatively correlated with faecal butyrate concentration
in carcinogen-treated rats (McIntry et al. 1993). They concluded that the protective effect of
wheat bran is due to its ability to maintain butyrate production in the distal colon where the
majority of tumours occur. In contrast, Zoran and co-workers (1997) compared the effects of oat
bran and wheat bran in a rat colon cancer model and found no relationship between tumour
formation and high butyrate concentrations in the distal colon. Rats fed oat bran had significantly
higher butyrate concentrations in both the proximal and distal colon but also significantly more
tumours than wheat bran-fed rats.
Antioxidants and phytoestrogens
In addition to the fibre content, fibre rich foods contain a number of other substances that may
have cancer preventive effects. Whole grains contain vitamins, trace minerals, and phenolic
compounds such as phytic acids and phytoestrogens. Of these compounds, vitamin E, selenium,
phenolic acids, and phytate have been proposed to function as antioxidants, protecting cells from
oxidative damage (Slavin et al. 1999). Phenolic compounds may also induce the detoxification
systems, specifically the phase II conjugation reactions.
Whole grains, especially rye and wheat, are rich sources of the plant lignans, so called
phytoestrogens, which are converted by gut bacteria to the mammalian lignans enterolactone and
enterodiol (Adlercreutz and Mazur 1997). These phytoestrogens have been proposed to bind
weakly to the oestrogen receptor and therefore they may have either a mild oestrogen-like action
or they may antagonise oestrogen action. Phytoestrogens may have relevance in colon cancer
prevention because age-related hypermethylation of the oestrogen receptor gene is currently
thought to be one of the molecular pathways leading to colon cancer (Issa et al. 1994). In colon
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cancer cells, hypermethylation results in inactivation of the oestrogen receptor gene, which is
accompanied by deregulated growth (Issa et al. 1994). Circulating oestrogens have been shown to
modulate the expression of oestrogen receptor in several tissues (Tata et al. 1993), suggesting
that blood levels of oestrogens or phytoestrogens might be able to attenuate the inactivating effect
of hypermethylation on the oestrogen receptor gene. This hypothesis is supported by some
epidemiological studies which have shown that postmenopausal oestrogen replacement is
associated with a reduced risk of colon cancer (reviewed in Giovannucci and Platz 1999).
Furthermore, in carcinogen-treated rats feeding phytoestrogen sources, such as flaxseed or lignan
precursor, inhibits ACF formation in the colon (Serraino and Thompson 1992, Jenab and
Thompson 1996). However, it is not yet clear whether these tumour preventive effects of
phytoestrogens are really oestrogen receptor mediated since these compounds have not always
shown oestrogenic or antioestrogenic activity or response though they have been effective in
inhibiting tumour growth (Saarinen et al. 2000).
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5. OBJECTIVES OF THE STUDY
Diet is considered to be one of the most important environmental contributors to the development
of colon cancer. Based on epidemiological findings, the main three dietary factors thought to
modulate colon carcinogenesis are fat, red meat, and fibre rich foods. A number of
epidemiological and experimental studies have tried to determine the relationship between these
dietary factors and colonic tumour formation but the results have been more or less controversial.
Therefore, studies elucidating the mechanisms by which diet may modulate colon tumourigenesis
would help in setting future dietary recommendations. This dissertation summarises the results of
six studies which were carried out to determine the effects of fat, red meat, and different fibre
sources on cell signal transduction molecules, mainly on PKC, in the colonic mucosa of healthy
rats and on tumour development in the intestine of Min mice.
This dissertation specifically aims to answer the following questions:
1. Do type and amount of dietary fat, red meat (beef) or different fibre sources affect steady-
state PKC activity and isozyme expression in the colonic mucosa of rats (I, II, III, IV, V)?
2. Are these effects mediated by changes in mucosal phospholipid fatty acid composition and/or
faecal DAG (II, III, V)?
3. Does beef affect colonic sphingomyelinase activities (III, IV)?
4. Are the effects of beef related to its arachidonic acid content (III)?
5. Do dietary fat, beef, and different fibre sources modulate intestinal tumour development in
Min mice (VI)?
6. Could the dietary effects on tumour development be explained by changes in PKC and β-
catenin (VI)?
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6. STUDY DESIGNS AND METHODS
6.1 Study designs and diets
Studies I and II
These two studies were carried out to determine whether type and amount of dietary fat affect
steady-state PKC activity in rat colonic mucosa. In Study I, rats were fed one of the three high-fat
diets (43% energy from fat) containing either butter (high in saturated fatty acids), rapeseed oil
(high in n-9 fatty acids), or sunflower seed oil (high in n-6 fatty acids) as a fat source. The control
group was fed a low-fat (10% of energy) sunflower-seed-oil diet. Total PKC activity and fatty
acid composition of the colonic mucosa were analysed after a four-week feeding period.
Because the results of Study I indicated that a high-fat butter diet increases colonic PKC activity,
Study II was done to see whether this observation is typical of saturated fats in general or specific
for fats rich in certain types of saturated fatty acids, i.e. palmitic (16:0) and stearic (18:0) acids.
Therefore, the effects of two different saturated fats, butter and coconut oil, were compared in
Study II. Two levels of the fats (10% and 43% of energy) were used to study the effect of fat
amount on PKC activity. Because dietary fat is likely to affect colonic PKC activity by
modulating PKC activators in luminal contents and/or mucosal cells, faecal DAG concentration
and mucosal phospholipid fatty acid composition were analysed.
Studies III and IV
Study III consisted of two experiments referred to as IIIa and IIIb. Study IIIa was done to
compare the effects of two protein sources, casein and beef, on colonic PKC activity and faecal
DAG concentration in rats. To ensure the same protein concentration of the AIN93G-based diets
(i.e. 20% by weight, Reeves et al. 1993), the beef was dried to constant moisture and ground
before addition to the diet. Apart from the protein composition, the beef diet differed from the
casein diet in that it contained lipids of cell membranes and a small amount of AA.
Study IIIa showed that the beef diet induced PKC activation in the colonic mucosa and therefore
Study IIIb was carried out to determine whether this effect was due to the small but possibly
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biological active amount of AA present in the beef diet. Because fish oil fatty acids are known to
antagonise several cellular functions induced by AA, a fish oil-supplemented group was also
included in the study. Rats were fed an AIN-93G basal diet which was supplemented with a daily
dose of 300 ml soybean oil (control group), or 8 mg of AA in 300 ml soybean oil, or a mixture of
99 mg of EPA and 67 mg of DHA. The supplements were given by syringe to ensure that each rat
received the proper dose. Mucosal PKC activity, PGE2 concentration, activities of acid, neutral
and alkaline sphingomyelinases, and fatty acid composition of phospholipids were analysed after
the supplementation period of four weeks.
Study IV was done to extend the findings of Study IIIa by determining the effects of a high-beef
diet on PKC isozyme expression. The PKC isozymes analysed were PKC α, β2, δ, ζ/λ,= and ζ.
Sphingomyelinase activities were also analysed.
Study V
Study V was designed to test whether different fibre sources are able to modulate PKC activity
and isozyme expression in rat colonic mucosa and if so, whether these effects are mediated by
changes in luminal DAG levels. Rats were fed one of the following AIN93G-based diets: a non-
fibre high-fat diet or one of the four high-fat diets supplemented with either rye, oat or wheat
bran or inulin at 100 g/kg diet. As the non-fibre diet was designed to approximate an average
human Western type diet its fat content was high, i.e. 40% of energy, and the ratio of
saturated:monounsaturated:polyunsaturated fatty acids was approximately 3:2:1 of the energy
given by fat. PKC activity was analysed in the proximal and distal colon separately and the level
of DAG in the contents of distal colon.
Study VI
Study VI was carried out to determine the effects of fat, red meat, and different fibre sources on
intestinal tumour development in Min mice. The mice were divided into seven diet groups: 1)
AIN93G diet with low fat content and 5% (w/w) of cellulose as a fibre source, 2) high-fat non-
fibre diet (the same as in Study V), 3-6) high-fat diets supplemented with 10% (w/w) of wheat,
rye, or oat brans or 2.5% (w/w) of inulin, 7) high-fat non-fibre diet with beef as a protein source.
After the feeding period of five to six weeks, the number and size of tumours in the small and
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large intestine were determined and mucosal levels of PKC isozymes and β-catenin were
analysed.
6.2 Animals and sample collection
The study protocols for all the experiments were approved by the Laboratory Animal Ethics
Committee of the Faculty of Agriculture and Forestry, University of Helsinki. Male weanling
Wistar rats were obtained from the National Laboratory Animal Centre, University of Kuopio,
Finland, for Studies I and II, from the Experimental Animal Facility of University of Helsinki,
Finland, for Studies III and IV, and from Harlan Co., The Netherlands, for Study V. Male Min
mice (4-7 weeks of age) for Study VI were obtained from the Jackson Laboratory, ME, USA.
During the experiments, rats and Min mice were housed in plastic cages in an animal facility with
a controlled temperature (20-22°C) and a 12 h light-dark cycle. During the experiments rats and
mice had free access to the diets and tap water. Body weights were recorded weekly. The number
of animals per dietary treatment group was 12 - 13 in the studies using rats and 7 - 9 in the study
using mice. In studies II, III, and V, each rat was kept in a metabolic cage for 1 to 2 d to collect
faeces. At the end of the feeding periods the animals were killed by CO2 asphyxiation.
In Studies II – V rat colons were removed, cut open longitudinally, and flushed clean with ice-
cold phosphate-buffered saline. The colons were divided into proximal and distal segments of
equal length; mucosas were scraped off with a microscope slide and used for biochemical
analysis. Study I differed from the other studies in that the proximal one-thirds of the colonic
mucosa was used for fatty acid analysis and the distal two-thirds for PKC activity analysis. The
caecal mucosa was used for phospholipid fatty acid analysis in Study II. It was collected
essentially in the same way as the colonic mucosa. Those tissue and faecal samples that were not
used for the analysis on the same day were frozen in liquid N2 and stored at -70°C.
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6.3 Methods
Tumour scoring in Study VI
The whole intestine of the Min mice in Study VI was removed, opened longitudinally, and
flushed with ice-cold physiological saline. The small intestine was divided into five segments of
equal length. The caecum and colon were kept together. The segments of the small intestine and
the large intestine were then spread out, mucosal surface up, on microscope slides and the
number, diameter, and location of tumours were determined using an inverse light microscope at
a magnification of x 2.5. The mucosa of the distal small intestine was then scraped off, frozen in
liquid N2, and stored at -70°C until used for PKC isozyme and β-catenin analyses.
PKC activity and isozyme expression
Mucosal samples from rat colon (I-V) and mice small intestine (VI) were homogenised by
sonication and ultracentrifuged at 100 000 g for 1 h. The supernatant was collected and used as
the cytosolic fraction. The pellet was resuspended in the extraction buffer containing 0.2% (v/v)
Triton X-100, incubated for 20 min and ultracentrifuged at 100 000 g for 1 h. The resulting
supernatant contained the membranes (particulate fraction). Cytosolic and membrane fractions
were further purified by DEAE-cellulose chromatography. PKC activity of the DEAE-purified
cytosolic and membrane fractions was assayed using a modification of the method described by
El Touny and co-workers (1990). In this method, PKCs activated by phosphatidylserine-
diacylglycerol vesicles phosphorylate a lysine-rich histone protein (histone III-S, Sigma, USA) in
the presence of [32P]ATP. PKC activity is expressed as pmol of 32P incorporated per min per mg
protein. The enzyme activity measured without the activators comprised 6-10% of the total PKC
activity. An addition of 50 µM myristoylated octapeptide (Bachem, Switzerland) to the reaction
mixture inhibited enzyme activity by 87% and 94% in cytosolic and membrane fractions
respectively. Protein concentrations of the crude and DEAE-purified fractions were measured
using a Bio-Rad protein assay reagent based on the Bradford method (Bradford 1976) with
bovine serum albumin as a standard.
For PKC isozyme analysis (IV, V, VI), 2 ml of the crude cytosolic and membrane extracts were
concentrated to 1/20 volume with Centrex UF-2 concentrators (Schleicher & Schuell, Germany).
41
The samples were then mixed with an equal volume of sodium dodecylsulphate (SDS) sample
buffer, boiled, and stored at -80oC until use. A pooled rat brain homogenate, containing both
cytosolic and membrane proteins, was used as a normalisation factor and a control for PKC
antibody specificity in immunoblotting analysis. Rat brain homogenate was prepared essentially
in the same way as described for the colon samples. Colonic mucosa samples (30-100 µg) and rat
brain homogenate (1-5 µg) were subjected to SDS-polyacrylamide gel electrophoresis using 10%
resolving gels (Laemmli 1970) and then transferred to polyvinylidene difluoride membranes
(Towbin 1979). Following transfer, the membranes were probed with antibodies for PKC α, β2,
δ, and ζ/λ by the method of Scheng and Schuster (1992), protocol B. Dilution of individual
primary antibody and alkaline phosphatase-conjugated secondary antibody was optimised for
each PKC isozyme. PKC bands were visualised by colorimetric staining of blots with 5-bromo-4-
chloro-3-indolyl phosphate and nitroblue tetrazolium substrate mix (Bio-Rad, CA, USA). Blots
were scanned on a Sharp JX325 Scanner and the scanning images were analysed with
ImageMaster 1D Software, version 2.0 (Pharmacia Biotech, Sweden). The results are expressed
as sample band intensity divided by rat brain band intensity. In preliminary experiments, a range
of protein concentrations for each isozyme was loaded onto gels to ensure that the colorimetric
signal was quantitatively detectable.
Phospholipid fatty acid composition
Total lipids of caecal (II) and colonic mucosa (III) were extracted by the method of Folch and co-
workers (1957). Phospholipids of colonic samples (III) were fractionated by thin layer
chromatography (silica gel 60, Merck, Germany). Thereafter samples were methylated as
described previously (Stoffel et al. 1959). The fatty acid methyl esters derived from total lipids or
different phospholipid fractions were analysed using a Hewlett Packard 5890 Series II gas
chromatograph (USA) equipped with a fused silica capillary column (NB-351, Nordion, Finland)
and an ultraviolet detector. The oven temperature was programmed to rise from 170°C to 230°C
at a rate of 4°C/min and then kept at 230°C for 8 min. Fatty acid peaks were identified by
comparison with a fatty acid methyl ester standard (GLC-91, Nu-Chec-Prep, MN, USA). The
proportions of individual fatty acids are expressed as percentages of the total fatty acids.
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PGE2
Colonic mucosal samples (III) were homogenised in 15% ethanol and centrifuged at 5000 g. The
supernatant was removed and acidified to pH 3. The samples were then purified by SepPak-C18
cartridges (Waters Assoc., MA, USA) according to Powell (1982) and their PGE2 content was
determined by enzyme immunological assay using a commercial kit (Cayman Chemical, MI,
USA). Prior to the purification procedure, 5000 cpm of  [3H]PGE2 was added to the samples to
assess recovery. Mucosal PGE2 is expressed as ng per mg sample protein.
DAG concentration in luminal contents and faeces
Lipids from luminal contents (V) and faecal samples (II, III) were extracted by a modified
method of Bligh and Dyer (1959). The lipid extracts were dried under nitrogen and used for
analysing the total amount of DAG by a commercial kit (Amersham, UK) based on the E. coli-
DAG-kinase method (Preiss et al. 1986). After the enzymatic reaction the samples were purified
by Amprep Si -columns (Amersham, UK) according to the manufacturer’s instructions and
subjected to scintillation counting.
β-Catenin expression
Mucosal samples of the distal small intestine of Min mice (VI) were treated in the same way as
samples for PKC isozyme analysis. The protein levels of β-catenin were determined in cytosolic
and particulate fractions by using monoclonal mouse β-catenin antibody (Transduction, KY,
USA) and alkaline phosphatase-conjugated anti-mouse secondary antibody (Zymed, CA, USA).
Quantitation of  β-catenin signal was as described for PKC isozymes.
Sphingomyelinase activities
Sphingomyelinase activities of colonic mucosal samples in Studies III and IV were kindly
analysed by Dr. Rui-Dong Duan’s group at the University Hospital of Lund, Sweden.
Sphingomyelinases were determined as described previously (Hertevig et al. 1997) with
modifications (Papers III and IV).
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Statistical analysis
One-way analysis of variance was used to compare variables among the dietary groups in Studies
I, II, IIIb, V, and VI. When the p value was < 0.05, means were separated using Tukey’s post
hoc-test. In Study IIIa, the unpaired t-test was used to compare the means between the beef and
casein groups. The differences between the proximal and distal colon were analysed by the paired
samples t-test. The correlation data were analysed by either the Pearson correlation analysis or a
linear regression analysis. The Systat statistical computer package (version 7.0, SPSS Inc., USA)
was utilised for all the statistical analyses.
7. RESULTS
7.1 Effects of fat, red meat, and fibre sources on colon signal transduction (PKC) in rats (I-
V)
Fat (I-II)
In Study I the high-fat butter diet resulted in increased membrane PKC activity in rat colonic
mucosa when compared with the low-fat control diet (p < 0.05; Figure 4a). PKC activity in rats
fed the high-fat rapeseed and sunflowerseed-oil diets was close to that in the control group. In
Study II we were unable to reproduce the increasing effect of butter on PKC activity though
membrane PKC activity in the distal colon appeared to be slightly higher in rats fed the butter
diets than in those fed the control diet (Figure 4b). There were also no dietary effects on PKC
activity in the proximal colon (Table 3 in Paper II). The effects of the coconut-oil diets on PKC
activity were essentially similar to those of the butter diets. The saturated fat diets caused
relatively small changes in fatty acid composition of caecal phospholipids, with rats fed the high-
fat coconut-oil diet having an increase in 14:0 and rats fed the high-fat butter diet having an
increase in 18:1n-9 when compared to the rats in the control group  (Tables 5 and 6 in Paper II).
The fatty acid composition of phosphatidylcholine was associated with membrane PKC activity
so that saturated fatty acids (14:0 and 18:0) were positive correlated and unsaturated fatty acids
(e.g. linolic acid, AA) were negatively correlated with membrane PKC activity (Figure 1 in Paper
II). Faecal DAG concentration was not significantly affected by the diets (Figure 4c).
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Figure 4. Effects of dietary fats on a) membrane PKC activity in whole colon mucosa, b)
membrane PKC activity in distal colon mucosa, and c) faecal DAG concentrations in rats. Values
are means and SD. Bars with different letters are significantly different (p < 0.05). LFC, low fat
control, HFB, high fat butter, HFRO, high fat rapeseed oil, HFSO, high fat sunflower seed oil,
LFB, low fat butter, LFCO, low fat coconut oil, HFCO, high fat coconut oil.
Red meat and arachidonic acid (III-IV)
Rats fed the beef diet had significantly higher membrane and cytosolic PKC activities in their
distal colons than rats fed the casein diet (p < 0.05 and p < 0.01 respectively; Figure 5a). The beef
diet induced PKC activity also in the proximal colon, though the effect was less pronounced than
in the distal colon (Table 3 in Paper III). Changes in distal PKC isozyme expression occurred,
with beef-fed rats having a higher level of cytosolic PKC α and a lower level of membrane PKC
δ than casein-fed rats (Figure 2 in paper IV). PKC ζ/λ was affected so that the level of 40 & 43
kDa fraction was higher and the level of 70 & 75 kDa fraction was lower in beef-fed rats (Figure
5b and 5c). There was no significant difference in faecal DAG concentrations between the beef
and casein groups (169 ± 33 vs. 158 ± 19 nmol/g wet faeces). DAG concentration was positively
correlated with the cytosolic PKC activity (Figure 1 in Paper III).
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    a)                                               b)                                               c)
Figure 5. Effects of the beef diet on a) PKC activity, and PKC ζ/λ protein levels b) in the cytosol
and c) in the membrane of rat distal colon. Values are means and SD. * and **, significantly
different from the casein group at p < 0.05 and p < 0.01, respectively.
Supplementation of AA with an amount equivalent to that available from the beef diet had no
effect on PKC activity in rat distal colonic mucosa. However, AA-supplemented rats had a
significant (p < 0.05) increase in proportion of AA in mucosal phosphatidylcholine compared
with the AIN93G control diet (Table 5 in Paper III). This was accompanied by an increase in
concentration of mucosal PGE2, which was significant only in comparison with the fish oil
supplemented group (Table 6 in Paper III). Neither beef nor AA and fish oil supplementations
affected the activities of acid, neutral, and alkaline sphingomyelinase (Table 6 in Paper III and
Table 3 in Paper IV).
Fibre sources (V)
In the distal colon, wheat bran feeding resulted in the lowest mucosal PKC activity and PKC β2
protein level, whereas oat bran and inulin feeding led to an increase in PKC activity and PKC β2
levels (Figure 6a and 6b). Rats fed the non-fibre control diet were between these two extremes.
Rye bran-fed rats had low PKC activity although their PKC β2 expression was rather increased
than decreased. DAG concentration in the contents of distal colon was the lowest in the non-fibre
and wheat bran groups which differed significantly (p < 0.05) from the rye bran group (Figure
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6c). The increasing effect of inulin on membrane and total PKC activity was even more
pronounced in the proximal than in the distal colon (Table 5 in Paper V). However, isozyme
expression differed so that, instead of PKC β2, inulin induced membrane PKC δ expression
(Table 3 in Paper V). There were also changes in expression of cytosolic PKC α and ζ/λ in the
proximal colon and cytosolic PKC δ and ζ/λ in the distal colon (Table 3 and 4 in Paper V).
   a)                                                              b)                                                         c)
Figure 6. Effects of diets enriched with different fibre sources on a) membrane PKC activity and
b) membrane PKC β2 protein levels in rat distal colon mucosa as well as c) DAG concentrations
in the distal colon contents. Values are means and SD. Bars with different letters are significantly
different (p < 0.05). NF, non-fibre high-fat, WB, wheat bran, RB, rye bran, OB, oat bran, INU,
inulin.
7.2 Effects of fat, red meat, and fibre sources on intestinal tumour development in Min mice
(VI)
In Min mice, the majority of tumours develop in the distal small intestine. The number of
tumours in the distal small intestine was lowest in mice fed the rye bran diet and highest in mice
fed the beef diet. The beef-fed mice differed significantly (p < 0.05) from mice fed the rye bran,
wheat bran, and AIN93G diets (Figure 7a). The inulin-fed mice had nearly as many tumours as
the beef-fed mice and they differed significantly from the mice fed the rye bran diet (Figure 7a).
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Though Min mice have only few tumours in their colons, the effects of the experimental diets on
colonic tumour development were in line with those seen in the small intestine (Table II in Paper
VI). Specifically, tumour incidence was only 33% in the rye bran group when compared with
89% in the beef group and 100% in the inulin group. There were no significant differences in
tumour size among the diet groups (Table III in Paper VI).
Figure 7. Effects of fat, beef, and fibre sources on a) intestinal tumour formation and b) mucosal
β-catenin protein level in Min mice. Values are means and SD. Bars with different letters are
significantly different (p < 0.05). NF, non-fibre high-fat, WB, wheat bran, RB, rye bran, OB, oat
bran, INU, inulin.
In general, the protein levels of PKC α, β2, δ, and ζ in the distal small intestinal mucosa of Min
mice were much higher in the cytosolic than in the membrane fraction. Membrane levels of PKC
α and δ were under the detection limit. There were large variations in PKC values within dietary
groups and no significant differences in PKC isozyme expression between the dietary groups
could be found (Table IV in Paper VI). Cytosolic β-catenin level was lowest in mice fed the rye
bran and beef diets and highest in mice fed the inulin and oat bran diets (Figure 7b). The inulin
group differed significantly (p < 0.05) from the non-fibre, rye bran, and beef groups, and the oat
bran group differed from the rye bran and beef groups. Cytosolic β-catenin level was
significantly correlated with all the PKC isozymes analysed (r = 0.62 – 0.68, p < 0.001).
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8. DISCUSSION
8.1. Fat
Dietary fat appeared to have no major role in modulating PKC activity in the colonic mucosa of
rats. The first study showed some indication that high-fat butter diet, rich in saturated fatty acids,
increases membrane PKC activity when compared to a low-fat basal diet and, to a lesser extent,
to high-fat rapeseed and sunflower-oil diets, rich in unsaturated n-9- and n-6-fatty acids,
respectively. The purpose of the second study was to determine further the role of saturated fats
in PKC activation but what could be seen was only a slight increasing effect of saturated fat on
PKC activity in the distal colon. There were also no difference between the effects of butter and
coconut oil, demonstrating that chain length of saturated fatty acids is not important (palmitic and
stearic acids vs. lauric and myristic acids). Results of two previous studies with rats indicated an
increase in membrane PKC activity by feeding beef tallow relative to feeding corn oil (Chapkin
et al. 1993) or low-fat basal diet  (Lafave et al. 1994).
The high-fat saturated diets had no effect on faecal DAG levels nor was there any correlation
between DAG and mucosal PKC activity. This result contradicts the assumption that high-fat
diets result in increased levels of faecal lipids and bile acids, which together enhance DAG
production by colonic bacteria (Morotomi et al. 1990 and 1991). The DAG produced could then
enter colonic epithelial cells and activate PKC, thereby causing a chronic state of increased cell
proliferation. Though this hypothesis sounds plausible it has actually never been verified in in
vivo studies.
The effects of butter and coconut oil on fatty acid composition of PC and PE fractions in caecal
mucosa were rather moderate and no dietary effects were observed, for example in the levels of
AA, a fatty acid considered to be important for signal transduction. The composition of PC was
more resistant to dietary induced changes than that of PE. This may partly account for the
relatively week effect of the fats on PKC activity, since PC hydrolysis products, DAG in
particular, are thought to maintain the sustained PKC activity needed for long-term cellular
responses in cells (Nishizuka 1995). Supporting the role of PC in regulating PKC activity, PC
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fatty acids were significantly correlated with membrane PKC activity. Generally, saturated fatty
acids were associated with increased and unsaturated fatty acids with decreased PKC activity. It
seems unlikely that these associations were mediated through PC hydrolysis products since
saturated DAG and saturated fatty acids have been week stimulators of PKC activity in vitro
(Hannun et al. 1986). Alternatively, PC as the main phospholipid in cell membranes affects cell
membrane physicochemical properties, which may have direct effects on PKC activity. This is
supported by a study of Slatter and co-workers (1994) that showed with artificial membranes that
increasing PC unsaturation in the presence of PE resulted in decreased PKC activity.
We could also see no promoting effect of a high-fat diet on intestinal tumour development in Min
mice. The adenoma number in mice fed the high-fat diet, the fat being mostly butter, was nearly
identical with mice fed the low-fat AIN93G diet. High-fat diets are generally considered to
increase colon cancer risk and especially beef tallow and corn oil have promoted colon
carcinogenesis in some (Reddy 1992, Wasan et al. 1997) but not all (Nauss et al. 1983)
experimental colon cancer studies. However, the promotive effect of fat may be partly explained
by its contribution to energy intake, since recent epidemiological studies (Howe et al. 1997) have
shown no independent effect of fat on colon cancer risk after adjustment for total energy intake.
8.2 Red meat
Beef feeding resulted in a significantly increased PKC activity both in the cytosolic and
membrane fractions of the distal colon of rats. The isozyme analysis gave no clear answer to the
question of which isozyme is responsible for the increased PKC activity. Cytosolic PKC α was
elevated in beef-fed rats compared with the casein-fed rats, but because PKC α requires DAG
and Ca2+ and presumably the membrane environment for activation (Newton 1995), it is not
likely to be active in the cytosol. In the membrane fraction, rats fed the beef diet showed no clear
increase in any of the isozymes measured. Therefore the changes seen in cytosolic and membrane
PKC ζ/λ expression, with beef-fed rats with a decrease in the 70 & 75 kDa fraction and an
increase in the 40 & 43 kDa fraction, may have accounted for the increased PKC activity.
Cellular fractions typically contain several immunoreactive bands of PKC ζ/λ (Davidson et al.
1994), probably as intermediate products of down-regulation (Yong et al. 1987). It has been
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suggested that the low molecular bands are proteolytical products of PKC that lack the regulatory
domain and are thus permanently active (Berra et al. 1993). Down-regulation of PKC ζ=and=λ is a
feature of carcinogen-induced colonic tumours in rats (Jiang et al. 1997a, Wali et al. 1995, Jiang
et al. 1997b, Roy et al. 1995), which has been blocked by feeding fish oil (Jiang et al. 1997a), a
1,25-dihydroxyvitamin D3 analogue (Wali et al. 1996) or a nonsteroidal anti-inflammatory drug
piroxicam (Roy et al. 1995). In line with epidemiological evidence, each of these agents was also
able to reduce colonic tumour formation.
Beef feeding did not alter luminal DAG levels, suggesting that the increased PKC activity in
beef-fed rats was not due to enhanced production of luminal DAG. Nevertheless, faecal DAG
was positively correlated with the cytosolic PKC activity, which leaves the possibility that more
DAG might have been produced and also taken up by colonocytes in beef-fed rats. DAG is
assumed to enhance the translocation of PKC to the cell membrane (Newton 1995) and therefore
the correlation of DAG to the cytosolic instead of membrane PKC activity was unexpected.
However, as has been shown to occur in fibroblasts, DAG taken up by cells may also have been
broken down to monoacylglycerol and fatty acids (Florin-Christensen et al. 1992). Based on in
vitro studies, cis-unsaturated fatty acids are capable of selectively activating cytosolic PKC
(Khan et al. 1991). Furthermore, DAG fatty acid compositions may have differed in the dietary
groups. Though beef tallow was added to the casein diet to achieve similar fat concentrations and
fatty acid compositions for the diets, the beef diet contained a small amount of AA, which was
not present in the casein diet. Therefore the beef-fed rats may have had faecal DAG species
containing more AA and being more effective in activating cytosolic PKC.
Because AA might have contributed to PKC activity by modulating not just DAG but
phospholipid fatty acid composition, it was interesting to test whether the AA content of the beef
diet was the reason for the increased PKC activity. This was, however, not the case since
supplementation of AA at a level equal to that available from the beef diet caused no changes in
mucosal PKC activity even though AA supplementation did increase the AA content of the PC
fraction. In contrast to this result, a short-term exposure (10-min) of colon epithelium to free AA
caused an increase in mucosal PKC activity in rats (Craven and DeRubertis 1988). However, it is
likely that long-term effects of dietary AA differ from those of a short-term exposure. A fish oil
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supplemented group was also included in the study because fish oil fatty acids are considered to
antagonise several cellular functions induced by AA (Li et al. 1994). Fish oil supplementation
had no effect on PKC activity. The results from previous in vivo studies with fish oil have been
controversial, and both a decrease (Reddy et al. 1996) and an increase (Chapkin et al. 1993) in
membrane PKC activity compared with corn oil feeding have been reported. It should be noted
that the amount of fish oil given to rats in our study was considerably less than that in the
previous studies. Also, there is evidence that large amounts of fish oil do alter PKC isozyme
expression and that these changes are associated with inhibition of the carcinogenic process in rat
colon  (Jiang et al. 1997a and 1997b).
Because AA is the major precursor of eicosanoids and may affect sphingolipid metabolism, both
of which are proposed to be involved in colon carcinogenesis, we also analysed mucosal PGE2
concentration and sphingomyelinase activities. It is of interest that AA supplementation resulted
in an increase in mucosal PGE2, indicating that diets high in beef might modulate intestinal
eicosanoid production. This is important considering the apparently significant role of COX-2 in
colon carcinogenesis (Williams et al. 1997). Fish oil supplementation, on the other hand, caused
a decrease in PGE2 concentration, which has been demonstrated in previous studies (Bartram et
al. 1993, Lee et al. 1993). Neither AA nor fish oil supplementation affected mucosal
sphingomyelinase activities, suggesting that mucosal ceramide production and thus the growth
suppressive pathways induced by ceramide were not altered. Apart from AA, beef contains other
cell membrane components, such as sphingomyelin (Blank et al. 1992), which may modulate
sphingomyelin activity. Therefore it was later checked whether the beef-fed rats had changes in
their colon sphingomyelin activities. However, activities of acid, neutral, and alkaline
sphingomyelinases were not different for the beef and casein-fed rats. Interestingly, acid
sphingomyelinase activity was significantly correlated with both PKC activity and PKC ζ protein
levels, which is in line with the previous in vitro studies showing that ceramide produced by acid
sphingomyelinase activates PKC ζ=(Lozano et al. 1994, Müller et al. 1995).
Consistent with the increase in PKC activity, the beef diet induced intestinal tumour development
in Min mice. The promoting effect on tumourigenesis could be seen in both the small intestine
and the colon. This result is in line with the recent prospective epidemiological studies that have
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shown a positive association between red meat intake and colon cancer risk (Willet et al. 1990,
Giovannucci et al. 1994). Experimental evidence concerning beef or red meat is limited and
inconsistent in nature, with results showing both promotive and preventive effects of red meat on
colon carcinogenesis (Nutter et al. 1983 and 1990, McIntosh et al. 1995). The discrepancy in
results of the earlier studies is likely to be due to differences in other components of diets and in
the form in which meat is given to animals. It is interesting that the beef-fed mice had no increase
in their cytosolic β-catenin levels since elevation of cytosolic free β-catenin is considered to be
the immediate reason for abnormal cell growth and thus for tumourigenesis in Min mice (Korinek
et al. 1997). It is possible that beef feeding enhanced tumour formation by affecting cellular
targets down-stream of β-catenin.
8.3 Fibre Sources
Feeding diets enriched with cereal brans or inulin modulated both PKC activity and isozyme
expression in the rat colon. Overall, PKC activity in rats fed the wheat and rye bran diets was at
the same level or lower than in rats fed the non-fibre diet, whereas rats fed the inulin and oat bran
diets had increased PKC activity. In the distal colon, these changes in PKC activity were
accompanied by changes in protein levels of membrane PKC β2, indicating activation of this
particular isozyme in the inulin and oat bran groups. There is considerable evidence to suggest
that PKC β2 is involved in colon cell proliferation and colon carcinogenesis. In colon cancer cell
lines, PKC β2 has been directly linked to cell proliferation (Sauma et al. 1996, Sauma and
Friedman 1996), which is supported by studies revealing a distinct pathway through which PKC
β2 promotes mitosis in human leukemia cells (Gökmen-Polar and Fields 1998). In an in vivo-
study with transgenic mice, overexpression of PKC β2 led to hyperproliferation of colonic
epithelium and to an increased susceptibility for the formation of carcinogen-induced ACF
(Murray et al. 1999). Furthermore, PKC β2 expression and/or membrane association are
increased in colonic atypical crypts (Kahl-Rainer et al. 1996) as well as in tumours compared to
the surrounding normal mucosa (Craven and DeRubertis 1992, Davidson et al. 1994, Wali et al.
1995), indicating that PKC β2 may enhance malignant growth.
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The increasing effect of inulin on membrane PKC activity was even more pronounced in the
proximal than distal colon. However, protein level of membrane PKC δ, not PKC β2, was
increased in the proximal colon. Immunohistochemical studies have revealed the presence of
PKC δ especially in the terminally differentiated cells located at the top of colonic crypts (Kahl-
Rainer et al. 1996, Verstovsek et al. 1998), suggesting that PKC δ is needed for normal
colonocyte differentiation. PKC δ has also been implicated in mediating apoptosis in some colon
cancer cell lines (Weller et al. 1999). In colonic tumours of both human and animal origin, PKC
δ has been mostly down regulated, presumably due to prolonged activation of the enzyme at the
early phase of the tumourigenic process (Kahl-Rainer et al. 1994, Wali et al. 1995). Taken
together, increased PKC activity in the inulin-fed rats may indicate that these animals are prone
to down-regulation of PKC δ.
In line with PKC activity, DAG concentration in the contents of distal colon was the lowest in
rats fed wheat bran and elevated in rats fed the oat bran and inulin diets. However, the rye bran-
fed rats were an exception since they had the highest faecal DAG level but their PKC activity was
as low as in the wheat bran group. Furthermore, though at least partly due to the rye bran group,
no significant correlation could be found between DAG and PKC activity, suggesting that
luminal DAG is not the major modulator of mucosal PKC activity. Only two previous in vivo-
studies have attempted to determine the effects of fibre on faecal DAG even though neither
analysed mucosal PKC activity. One of these showed that supplementation of wheat bran at 15 g
per day for eight weeks reduces faecal DAG concentration in women (Reddy et al. 1994), which
is in agreement with our results. The other study showed that cellulose relative to pectin at the
level 6g/100g in diet enhanced faecal DAG excretion in rats (Pickering et al. 1995). The authors
concluded that this is probably due to a decrease in the uptake of DAG by epithelial cells and
might partly explain the inhibiting effect of cellulose on colon carcinogenesis. The cellulose
content as well as other dietary fibre components are largely similar in wheat and rye brans and
therefore their opposite effects on luminal DAG in our study are not easily explained. It might be
related to a specific effect of either of these brans on gut microbes producing the luminal DAG.
Because the effects of the fibre sources are not fully explained by changes in faecal DAG, there
have to be other mechanisms whereby these fibre sources affect PKC. In addition to DAG,
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concentrations of the three main SCFAs butyrate, propionate, and acetate, as well as activities of
certain faecal bacterial enzymes were analysed in the colonic contents of the same rats used for
PKC analysis (M Mutanen, A-M Pajari, S Gråsten, and K Liukkonen, unpublished data). No
relation between any of the SCFAs and PKC activity or isozyme levels could be found. This is in
agreement with a recent in vitro study which showed that PKC does not mediate the
differentiating effects of butyrate on colon cancer cells, though its activity augments the effects of
butyrate (Rickard et al. 1999). In some other cell types, butyrate has greatly stimulated PKC
activity and modulated the expression of the PKCs β and ε isozymes (Rivero et al. 1998). The
bacterial enzymes analysed in our work were β-glucuronidase, β-glucosidase, and urease. Of
these, faecal urease activity was significantly but not very strongly (r = 0.4, p < 0.05) correlated
with membrane PKC activity and membrane PKC β2 levels in the distal colon. Even though all
the fibre sources tended to increase faecal urease activity compared to the non-fibre diet, the oat
bran diet resulted in the highest urease activity. This is of interest because readily fermentable
fibres have been shown to promote bacterial growth driven diffusion of blood urea into the
caecum (Lupton and Marchant 1989, Younes et al. 1996), which may lead to increased levels of
luminal ammonia by urease-positive bacteria (Lupton and Marchant 1989). Ammonia, in turn,
may damage mucosal cells (Lin and Visek 1991a and 1991b) and result in increased proliferation
as a compensatory mechanism for cell loss. Thus, the relation between luminal urease activity
and mucosal PKC is probably indirect in nature. Faecal bile acids were not analysed and
therefore the possibility that the fibre sources have exerted differential effects on the formation
and binding of secondary bile acids can not be excluded. Secondary bile acids are known to be
particularly potent activators of PKC β (Pongacrz et al. 1995).
The diet induced changes in membrane PKC activity and PKC β2 in the distal colon of rats
appeared to predict well the tumour outcome in the intestine of Min mice. Both inulin and oat
bran feeding clearly enhanced tumour formation in the intestine of Min mice compared to the
non-fibre diet, whereas wheat and especially rye bran resulted in inhibition of tumour formation.
Our results are in good agreement with a number of previous experimental studies on the role of
fibres in colon carcinogenesis. Wheat bran has protected against tumour development in nearly
every experimental model used, including both the rat colon carcinogen model (McIntry et al.
1993, Zoran et al. 1997) and APC knockout mice (Hioki et al. 1997). Rye bran has been studied
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once and it was found to be protective in the AOM-model of rat colon carcinogenesis (Davies et
al. 1999). Readily fermentable fibre sources, such as oat bran, guar gum, and pectin, have not
offered protection but in some cases they have promoted colonic tumour formation (Jacobs and
Lupton 1986, McIntry et al. 1993, Zoran et al. 1997). Inulin, a chicory fructan, is highly
fermentable but it has been suggested to selectively stimulate the growth of beneficial bacteria in
the colon and thus improve the host’s health (Gibson and Roberfroid 1995). Inulin has been
found to reduce the formation of preneoplastic ACF when added to a basal AIN-76 diet (Reddy et
al. 1997) or a high-fat corn oil diet (Rowland et al. 1998), indicating that inulin inhibits colon
carcinogenesis. In respect to inulin the result of the present study contradicts those of previous
studies, which could be explained by several reasons. First, the low fat concentration and the
presence of cellulose in the AIN-76 diet as well as the high n-6 fatty acid content of the corn oil
diet may not optimally reflect a human high-risk diet that is considered to be high in saturated fat
and low in fibre. Second, the correlation between the multiplicity of ACF and the tumours that
finally develop has not always been straightforward (Hardman et al. 1991).
The fibre sources had no significant effects on protein levels of PKC α, β2, δ, and ζ isozymes in
Min mice. This is probably due to the fact that the neoplastic process in Min mice at the end of
the feeding period was beyond the state in which diet can modulate PKC expression. This is
supported by the observation that protein levels of PKC α and δ were under the detection limit in
the membrane fraction and they could be measured only from the cytosolic fraction, indicating
their full down regulation. A defect in PKC isozyme analysis was that tumour tissue was not
separated from the surrounding mucosa, which might have masked the dietary effects. A very
recent study by Klein and co-workers (2000) demonstrated reduced protein expression of PKC α,
β1, and ζ specific for adenoma tissue in Min mice.
Mice fed the rye bran diet had the lowest and mice fed the inulin and oat bran diets had the
highest level of cytosolic β-catenin, suggesting that the immediate mediator of the effects of the
fibre sources on tumour formation in Min mice is their ability to modulate β-catenin levels.=Ιn
Min mice, Apc protein functions poorly due to a mutation in the Apc gene, which leads to
abnormal accumulation of cytosolic free β-catenin (Mahmoud et al. 1997). This β-catenin
translocates to the nucleus, where it binds to the Tcf transcription factor and promotes cell
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proliferation by enhancing expression of target genes, such as c-myc (He et al. 1998). The present
study is one of the first to demonstrate that β-catenin, the key molecule in this process, can be
modulated by dietary means. Exactly how the fibre sources affect β-catenin levels is yet unclear.
However, it is of interest that all PKC isozymes analysed were positively correlated with
cytosolic β-catenin levels. A number of recent studies have demonstrated that PKC isozymes
interact with the APC/β-catenin pathway and that they may have distinct roles in regulating β-
catenin level or function. Specifically, PKCs have been shown in vitro to mediate inhibition of
GSK3β activity (Cook et al. 1996), presumably by causing its phosphorylation (Goode et al.
1992). In intestinal epithelial cell line, activation of PKC with phorbol 12-myristate 13-acetate
triggered the translocation of β-catenin to the nucleus and enhanced β-catenin/Tcf-4 mediated
transcription (Baulida et al. 1999). The most compelling evidence comes from an in vivo study,
in which transgenic mice overexpressing PKC β2 had decreased GSK3β activity as well as
elevated β-catenin levels (Murray et al. 1999).
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9. CONCLUSIONS AND FUTURE PERSPECTIVES
Based on the results, it appears that fats do have no major effect on PKC activation or tumour
development in the intestinal mucosa of rats and Min mice. However, beef resulted in elevation
of steady-state PKC activity in the colonic mucosa of rats as well as enhanced intestinal tumour
development in Min mice. The effects of different fibre sources on PKC and tumour formation
differed depending on the fibre type in question. The readily fermentable fibre sources inulin and
oat bran resulted in an increase in PKC activity and PKC β2 expression in rat colon and enhanced
tumour development in the intestine of Min mice, whereas wheat and rye brans resulted in low
PKC activity and PKC β2 expression together with suppressed tumour development in Min mice.
Simply an increase in total PKC activity in the colonic mucosa of healthy animals seems to
predict surprisingly well the tumour outcome, which could be seen in the animals fed beef and
inulin. Accordingly, a decrease in PKC activity in normal colonic mucosa would be expected to
lead to inhibition of tumour development, which was at least partly true in respect of rye and
wheat brans. Of the PKC isozymes, PKC β2 is perhaps most closely linked to the carcinogenic
process in the colon, since an increase in PKC β2 expression was as good predictor of tumour
outcome as PKC activity. One reason for this may be that PKC β2 seems to be an important
mediator of colon cell proliferation. Disturbances in proliferation may result in a
hyperproliferating colonic epithelium, which is considered to be the very first stage in the
transforming process of normal epithelium to colon cancer. Also, changes in PKC ζ and λ
expression may be of importance, as suggested by the results concerning beef feeding. The
specific functions of atypical PKCs in the colon are far less clear than those of conventional and
novel PKCs. Presumably atypical PKCs regulate maturation and growth of colonocytes. The
changes in PKC in the distal colonic mucosa appear to be the most important determinants of
tumour outcome. This is not surprising in view of the fact that colon tumours in high-incidence
western countries are more common in the distal colon than in other sites (Bufill 1990).
It seems that PKC in the late phase of the neoplastic process no longer predict the tumour
outcome as could be seen in Min mice at the end of the feeding period. This result is, however,
tentative since there were limitations in PKC analysis in the Min mice study. It is noteworthy that
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PKC isozyme levels did correlate with cytosolic β-catenin level. This observation supports the
results from previous in vitro studies that have linked PKC to the APC pathway, one of the major
cellular pathways involved in colon carcinogenesis.
 In future studies, it is important to determine the changes in cellular events occurring at different
time points in the tumourigenic process. Specifically, it would be interesting to see how PKC
activity and certain isozymes change during the tumourigenic process and whether these changes
are linked to alterations in the APC-pathway, especially β-catenin levels. Furthermore, the result
of rye bran feeding being able to reduce β-catenin levels in Min mice suggests that diet might be
a powerful modulator of the molecular events leading to colon cancer. The exact effects of
dietary factors on these events are worthy of further studies.
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